Home > Insider Trading > Filing (0001209191-21-070605)

Filing Details

Accession Number:: 0001209191-21-070605
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-12-20 17:20:57
Reporting Period:: 2021-12-20

Accepted Time:: 2021-12-20 17:20:57
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1442145	Verisk Analytics Inc.	VRSK	Services-Computer Processing & Data Preparation (7374)	262994223

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1472710	V Mark Anquillare	C/O Verisk Analytics, Inc. 545 Washington Boulevard Jersey City NJ 07310	Group President And Coo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-12-20	20,480	$61.14	41,982	No	4	M	Direct
Common Stock	Disposition	2021-12-20	300	$214.71	41,682	No	4	S	Direct
Common Stock	Disposition	2021-12-20	400	$216.02	41,282	No	4	S	Direct
Common Stock	Disposition	2021-12-20	4,600	$216.82	36,682	No	4	S	Direct
Common Stock	Disposition	2021-12-20	7,968	$217.98	28,714	No	4	S	Direct
Common Stock	Disposition	2021-12-20	7,212	$219.18	21,502	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2021-12-20	20,480	$0.00	20,480	$61.14

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2023-04-01	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	57,000	Indirect	By Trust
Common Stock	9,027	Indirect	By Trust

Footnotes

These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $214.56 to $215.00, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (1).
These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $215.80 to $216.43, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (2).
These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $216.77 to $217.54, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (3).
These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $217.56 to $218.46, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (4).
These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $218.57 to $219.55, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (5).
These shares of common stock are held by the Mark Anquillare Spousal Living Trust.
These shares of common stock are held in a Revocable Trust.
This stock option was granted under the Issuer's 2009 Equity Incentive Plan.
Immediately.